Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Chinese Herb Significantly Reduces Alcohol Intake, Study Finds
Researchers at Harvard-affiliated McLean Hospital, In a paper published in the May issue of Alcoholism: Clinical and Experimental Research, note that Chinese herb kudzu appears to be an effective treatment for managing excessive alcohol consumption, particularly binge drinking.
- Chinese Herb Significantly Reduces Alcohol Intake, Study Finds
Researchers at Harvard-affiliated McLean Hospital, In a paper published in the May issue of Alcoholism: Clinical and Experimental Research, note that Chinese herb kudzu appears to be an effective treatment for managing excessive alcohol consumption, particularly binge drinking.
- Chinese Herb Significantly Reduces Alcohol Intake, Study Finds
Researchers at Harvard-affiliated McLean Hospital, In a paper published in the May issue of Alcoholism: Clinical and Experimental Research, note that Chinese herb kudzu appears to be an effective treatment for managing excessive alcohol consumption, particularly binge drinking.
- New Study Suggests Positive Effect Of Flax Lignan Extract On Prostate Health
Recent rat study with LinumLife® EXTRA indicates that supplementation leads to reduction of the prostate size.
- New Study Suggests Positive Effect Of Flax Lignan Extract On Prostate Health
Recent rat study with LinumLife® EXTRA indicates that supplementation leads to reduction of the prostate size.
- New Study Suggests Positive Effect Of Flax Lignan Extract On Prostate Health
Recent rat study with LinumLife® EXTRA indicates that supplementation leads to reduction of the prostate size.
- New Study Suggests Positive Effect Of Flax Lignan Extract On Prostate Health
Recent rat study with LinumLife® EXTRA indicates that supplementation leads to reduction of the prostate size.
- Dietary Supplement a Potential Treatment for Canavan Disease
Research suggests that supplementation with N-acetylaspartic acid (NAA)-derived acetate would increase synthesis of myelin-related fatty acids and lipids and could be potential therapy for Canavan disease.
- Dietary Supplement a Potential Treatment for Canavan Disease
Research suggests that supplementation with N-acetylaspartic acid (NAA)-derived acetate would increase synthesis of myelin-related fatty acids and lipids and could be potential therapy for Canavan disease.
- Dietary Supplement a Potential Treatment for Canavan Disease
Research suggests that supplementation with N-acetylaspartic acid (NAA)-derived acetate would increase synthesis of myelin-related fatty acids and lipids and could be potential therapy for Canavan disease.
- Dietary Supplement a Potential Treatment for Canavan Disease
Research suggests that supplementation with N-acetylaspartic acid (NAA)-derived acetate would increase synthesis of myelin-related fatty acids and lipids and could be potential therapy for Canavan disease.
- Susan Lark, MD, and Healthy Directions Develop Nutritional Formula for Balancing Digestive Health
Susan Lark, MD has formulated Daily Balance Probiotic Answer, a nutritional supplement targeted at women's digestive systems; product is available exclusively through Doctors' Preferred, LLC, a subsidiary of Healthy Directions.
- Susan Lark, MD, and Healthy Directions Develop Nutritional Formula for Balancing Digestive Health
Susan Lark, MD has formulated Daily Balance Probiotic Answer, a nutritional supplement targeted at women's digestive systems; product is available exclusively through Doctors' Preferred, LLC, a subsidiary of Healthy Directions.
- Susan Lark, MD, and Healthy Directions Develop Nutritional Formula for Balancing Digestive Health
Susan Lark, MD has formulated Daily Balance Probiotic Answer, a nutritional supplement targeted at women's digestive systems; product is available exclusively through Doctors' Preferred, LLC, a subsidiary of Healthy Directions.
- Susan Lark, MD, and Healthy Directions Develop Nutritional Formula for Balancing Digestive Health
Susan Lark, MD has formulated Daily Balance Probiotic Answer, a nutritional supplement targeted at women's digestive systems; product is available exclusively through Doctors' Preferred, LLC, a subsidiary of Healthy Directions.
- Susan Lark, MD, and Healthy Directions Develop Nutritional Formula for Balancing Digestive Health
Susan Lark, MD has formulated Daily Balance Probiotic Answer, a nutritional supplement targeted at women's digestive systems; product is available exclusively through Doctors' Preferred, LLC, a subsidiary of Healthy Directions.
- Susan Lark, MD, and Healthy Directions Develop Nutritional Formula for Balancing Digestive Health
Susan Lark, MD has formulated Daily Balance Probiotic Answer, a nutritional supplement targeted at women's digestive systems; product is available exclusively through Doctors' Preferred, LLC, a subsidiary of Healthy Directions.
- Susan Lark, MD, and Healthy Directions Develop Nutritional Formula for Balancing Digestive Health
Susan Lark, MD has formulated Daily Balance Probiotic Answer, a nutritional supplement targeted at women's digestive systems; product is available exclusively through Doctors' Preferred, LLC, a subsidiary of Healthy Directions.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Imperial Optical, Inc. Partners with DaVinci Laboratories
contact lens distributor and natural supplement and nutraceuticals provider partner to offer to provide online access to an exclusive line of eye health supplements to Imperial Optical’s ECP WebSolutions subscribers.
- Imperial Optical, Inc. Partners with DaVinci Laboratories
contact lens distributor and natural supplement and nutraceuticals provider partner to offer to provide online access to an exclusive line of eye health supplements to Imperial Optical’s ECP WebSolutions subscribers.
- Imperial Optical, Inc. Partners with DaVinci Laboratories
contact lens distributor and natural supplement and nutraceuticals provider partner to offer to provide online access to an exclusive line of eye health supplements to Imperial Optical’s ECP WebSolutions subscribers.
- Imperial Optical, Inc. Partners with DaVinci Laboratories
contact lens distributor and natural supplement and nutraceuticals provider partner to offer to provide online access to an exclusive line of eye health supplements to Imperial Optical’s ECP WebSolutions subscribers.
- Study Indicates That GliSODin® May Provide Significant Protection Against UV Radiation-induced Skin Changes
In double-blind, placebo controlled study, UV skin burn (actinic erythema) was induced on the inner-forearms of healthy subjects before supplementation with GliSODin or placebo, and each week for four weeks during supplementation; color of the skin was measured by chromometry, and changes in skin due to inflammation were assessed by videocapillaroscopy.
- Study Indicates That GliSODin® May Provide Significant Protection Against UV Radiation-induced Skin Changes
In double-blind, placebo controlled study, UV skin burn (actinic erythema) was induced on the inner-forearms of healthy subjects before supplementation with GliSODin or placebo, and each week for four weeks during supplementation; color of the skin was measured by chromometry, and changes in skin due to inflammation were assessed by videocapillaroscopy.
- Study Indicates That GliSODin® May Provide Significant Protection Against UV Radiation-induced Skin Changes
In double-blind, placebo controlled study, UV skin burn (actinic erythema) was induced on the inner-forearms of healthy subjects before supplementation with GliSODin or placebo, and each week for four weeks during supplementation; color of the skin was measured by chromometry, and changes in skin due to inflammation were assessed by videocapillaroscopy.
- Study Indicates That GliSODin® May Provide Significant Protection Against UV Radiation-induced Skin Changes
In double-blind, placebo controlled study, UV skin burn (actinic erythema) was induced on the inner-forearms of healthy subjects before supplementation with GliSODin or placebo, and each week for four weeks during supplementation; color of the skin was measured by chromometry, and changes in skin due to inflammation were assessed by videocapillaroscopy.
- Irritable Bowel Syndrome (IBS) Study - Recruiting Completed
Company announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
- Irritable Bowel Syndrome (IBS) Study - Recruiting Completed
Company announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
- Irritable Bowel Syndrome (IBS) Study - Recruiting Completed
Company announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
- Irritable Bowel Syndrome (IBS) Study - Recruiting Completed
Company announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Raisins As A Functional Food For Oral Health
Researchers at the University of Illinois at Chicago School of Dentistry have determined that compounds in raisins suppress bacteria that cause cavities and gum disease. According to research presented at the meeting of the American Society for Microbiology, five compounds (oleanolic acid, oleanolic aldehyde, betulin, betulinic acid and 5-(hydroxymethyl)-2-furfural) seem to make teeth and gums healthier, in the case of oleanic acid, by slowing growth of a cavity causing bacteria and inhibiting the bacteria from sticking to surfaces.
- Raisins As A Functional Food For Oral Health
Researchers at the University of Illinois at Chicago School of Dentistry have determined that compounds in raisins suppress bacteria that cause cavities and gum disease. According to research presented at the meeting of the American Society for Microbiology, five compounds (oleanolic acid, oleanolic aldehyde, betulin, betulinic acid and 5-(hydroxymethyl)-2-furfural) seem to make teeth and gums healthier, in the case of oleanic acid, by slowing growth of a cavity causing bacteria and inhibiting the bacteria from sticking to surfaces.
- Raisins As A Functional Food For Oral Health
Researchers at the University of Illinois at Chicago School of Dentistry have determined that compounds in raisins suppress bacteria that cause cavities and gum disease. According to research presented at the meeting of the American Society for Microbiology, five compounds (oleanolic acid, oleanolic aldehyde, betulin, betulinic acid and 5-(hydroxymethyl)-2-furfural) seem to make teeth and gums healthier, in the case of oleanic acid, by slowing growth of a cavity causing bacteria and inhibiting the bacteria from sticking to surfaces.
- Raisins As A Functional Food For Oral Health
Researchers at the University of Illinois at Chicago School of Dentistry have determined that compounds in raisins suppress bacteria that cause cavities and gum disease. According to research presented at the meeting of the American Society for Microbiology, five compounds (oleanolic acid, oleanolic aldehyde, betulin, betulinic acid and 5-(hydroxymethyl)-2-furfural) seem to make teeth and gums healthier, in the case of oleanic acid, by slowing growth of a cavity causing bacteria and inhibiting the bacteria from sticking to surfaces.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- Advitech Announces Completion of 2nd Study on XP-828L For Psoriasis
multi-centre, randomized double-blind, placebo-controlled study was conducted over a 112-day period; final results to be released July 5, 2005.
- Advitech Announces Completion of 2nd Study on XP-828L For Psoriasis
multi-centre, randomized double-blind, placebo-controlled study was conducted over a 112-day period; final results to be released July 5, 2005.
- Advitech Announces Completion of 2nd Study on XP-828L For Psoriasis
multi-centre, randomized double-blind, placebo-controlled study was conducted over a 112-day period; final results to be released July 5, 2005.
- Advitech Announces Completion of 2nd Study on XP-828L For Psoriasis
multi-centre, randomized double-blind, placebo-controlled study was conducted over a 112-day period; final results to be released July 5, 2005.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- Advitech Announces Positive Results of XP-828L Study In Psoriasis
Company reports positive results from its recently completed randomized, multi-center, double-blind, placebo-controlled clinical trial of XP-828L, confirming efficacy and safety.
- Advitech Announces Positive Results of XP-828L Study In Psoriasis
Company reports positive results from its recently completed randomized, multi-center, double-blind, placebo-controlled clinical trial of XP-828L, confirming efficacy and safety.
- Advitech Announces Positive Results of XP-828L Study In Psoriasis
Company reports positive results from its recently completed randomized, multi-center, double-blind, placebo-controlled clinical trial of XP-828L, confirming efficacy and safety.
- Advitech Announces Positive Results of XP-828L Study In Psoriasis
Company reports positive results from its recently completed randomized, multi-center, double-blind, placebo-controlled clinical trial of XP-828L, confirming efficacy and safety.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
PROVO, Utah, June 2, 2005 /PRNewswire-FirstCall via COMTEX/ -- Pharmanex, a Nu Skin Enterprises (NUS) company, announced today a study that found Tegreen 97(R) to provide blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects -- a precursor to type-2 diabetes. The findings of the new study were recently presented at the American Heart Association's Sixth Annual Conference in Washington, D.C.
"We are honored by the American Heart Association's invitation to present our newest findings on Tegreen 97," said Joe Chang, Ph.D., president of Pharmanex. "The results of this study are very meaningful in building a greater body of knowledge related to two significant health issues today: weight gain and lack of blood sugar control. We have shown with this and other studies that Tegreen 97 can have a significant beneficial effect in managing these two health conditions."
Tegreen 97(R) is a proprietary, decaffeinated green tea extract standardized to 97 percent polyphenols -- two-thirds of which are catechins, the element responsible for the observed effect. Each capsule of Tegreen 97(R) contains the same amount of catechins as seven cups of the traditionally brewed green tea drink.
About the Study
The purpose of this study was to examine the effects of Tegreen 97(R) in enhancing insulin sensitivity and improving glucose-lipid metabolism. In addition, the research examined the effects of the proprietary green tea supplement in lowering body weight and weight of abdominal fat and inhibiting angiogenesis, which is the formation and differentiation of blood vessels, a key pathological process in the development of abnormal cells. Angiogenesis is hypothesized to play an important role in development of obesity. Following are the results of the study:
* Tegreen 97(R) enhanced insulin sensitivity*
* Improved glucose-lipid metabolism*
* Increased fat burning and decreased body fat percentage*
* Lowered body weight associated with inhibited angiogenesis.*
"Our findings proved that in addition to its significance in protecting cells from abnormal mutation, inhibition of angiogenesis by Tegreen 97 is associated with reduction of body weight," said Josh Zhu, senior director of clinical R&D for Pharmanex and chief researcher of the study. "Tegreen 97 not only supports the general belief in the anti-aging benefits of tea catechins but may also provide benefits to people with Metabolic Syndrome X, overweight and those with subsequent cardiovascular and brain health concerns."
Tegreen 97(R) is also included in LifePak(R), the company's comprehensive multivitamin/mineral and antioxidant supplement.
Pharmanex
Pharmanex, a Nu Skin Enterprises company, applies pharmaceutical processes and scientific measurement to create nutritional supplements for more than 40 markets worldwide. Pharmanex(R) products are sold direct to the consumer through the Internet and a network of independent distributors. For more information, go to www.pharmanex.com.
The Company
Nu Skin Enterprises, Inc. is a global direct selling company operating in 40 markets throughout Asia, the Americas and Europe. The company markets premium quality personal care products under the Nu Skin(R) brand, science-based nutritional supplements under the Pharmanex(R) brand, and technology based products and services under the Big Planet(R) brand. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol "NUS."
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. |